Robyn Brown

Robyn Brown is an accomplished finance professional with extensive experience in the pharmaceutical industry. Currently serving as AVP of Finance at Organon since June 2021, Robyn previously held the position of Executive Director of Finance at Merck for over a decade, overseeing finance for the Manufacturing Division and managing partnerships and alliances. Additional prior roles include Vice President of Investor Relations at The Medicines Company and various finance-related positions at Schering-Plough, SGS North America, and Deloitte & Touche. Robyn holds an MBA in Finance from Fairleigh Dickinson University and a Bachelor of Science in Accounting from Villanova School of Business.